AstraZeneca Pharma India Ltd

NSE: ASTRAZEN · BSE: 506820 · Pharmaceuticals & Biotechnology · 6 announcements

Share price: ₹6,505.00
Market cap: ₹16,262 Cr
Revenue (annual): ₹2,276 Cr
Net profit (annual): ₹187.5 Cr
P/E (TTM): 95.9×Sector 50.4×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 2.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 2 Financial Results 2 Other Announcement 1 Management Change 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

2 Sep 2026 18:15 IST BSE

Other Announcement

AstraZeneca Pharma India Other Announcement

AstraZeneca Pharma India reported receiving an ESG rating of 64 from Crisil ESG Ratings. The assessment was independently prepared using publicly available information.

Read the filing ↗